244 related articles for article (PubMed ID: 21970791)
1. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Mahfooz N; Carl E; Drake A; Schneider J; Teter B; Hussein S; Mehta B; Weiskopf M; Durfee J; Bergsland N; Ramanathan M
J Neuroinflammation; 2011 Oct; 8():127. PubMed ID: 21970791
[TBL] [Abstract][Full Text] [Related]
2. Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Ramanathan M
J Neurol Sci; 2011 Dec; 311(1-2):86-91. PubMed ID: 21849177
[TBL] [Abstract][Full Text] [Related]
3. An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Tettey P; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; Kostner K; van der Mei I
Mult Scler; 2014 Nov; 20(13):1737-44. PubMed ID: 24829292
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Qu J; Cookfair D; Duan X; Bang E; Bergsland N; Hussein S; Cherneva M; Willis L; Heininen-Brown M; Ramanathan M
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):189-95. PubMed ID: 21047880
[TBL] [Abstract][Full Text] [Related]
5. Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study.
Fellows Maxwell K; Wahls T; Browne RW; Rubenstein L; Bisht B; Chenard CA; Snetselaar L; Weinstock-Guttman B; Ramanathan M
PLoS One; 2019; 14(6):e0218075. PubMed ID: 31211794
[TBL] [Abstract][Full Text] [Related]
6. An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event.
Tettey P; Simpson S; Taylor B; Ponsonby AL; Lucas RM; Dwyer T; Kostner K; ; van der Mei IA
J Neurol Neurosurg Psychiatry; 2017 May; 88(5):395-401. PubMed ID: 28320766
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipid peroxidation and progression of disability in multiple sclerosis.
Koch M; Mostert J; Arutjunyan AV; Stepanov M; Teelken A; Heersema D; De Keyser J
Eur J Neurol; 2007 May; 14(5):529-33. PubMed ID: 17437612
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
Weinstock-Guttman B; Zivadinov R; Horakova D; Havrdova E; Qu J; Shyh G; Lakota E; O'Connor K; Badgett D; Tamaño-Blanco M; Tyblova M; Hussein S; Bergsland N; Willis L; Krasensky J; Vaneckova M; Seidl Z; Ramanathan M
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1186-91. PubMed ID: 23595944
[TBL] [Abstract][Full Text] [Related]
9. Elevated Lipid Profiles in Patients with Acute Transverse Myelitis.
Liu J; Li M; Wang X; Yi H; Xu L; Peng FH
Eur Neurol; 2016; 75(3-4):142-8. PubMed ID: 26949935
[TBL] [Abstract][Full Text] [Related]
10. Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis.
Zhang Y; Zhou Y; van der Mei IAF; Simpson S; Ponsonby AL; Lucas RM; Tettey P; Charlesworth J; Kostner K; Taylor BV;
J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):636-641. PubMed ID: 30782980
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.
Uher T; Fellows K; Horakova D; Zivadinov R; Vaneckova M; Sobisek L; Tyblova M; Seidl Z; Krasensky J; Bergsland N; Weinstock-Guttman B; Havrdova E; Ramanathan M
J Lipid Res; 2017 Feb; 58(2):403-411. PubMed ID: 27923871
[TBL] [Abstract][Full Text] [Related]
12. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.
Zivadinov R; Weinstock-Guttman B; Hashmi K; Abdelrahman N; Stosic M; Dwyer M; Hussein S; Durfee J; Ramanathan M
Neurology; 2009 Aug; 73(7):504-10. PubMed ID: 19687451
[TBL] [Abstract][Full Text] [Related]
13. Low high-density lipoprotein cholesterol and high triglycerides lipid profile in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Cho EB; Cho HJ; Choi M; Seok JM; Shin HY; Kim BJ; Min JH
Mult Scler Relat Disord; 2020 May; 40():101981. PubMed ID: 32045867
[TBL] [Abstract][Full Text] [Related]
14. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up.
Murali N; Browne RW; Fellows Maxwell K; Bodziak ML; Jakimovski D; Hagemeier J; Bergsland N; Weinstock-Guttman B; Zivadinov R; Ramanathan M
Eur J Neurol; 2020 Jan; 27(1):188-e4. PubMed ID: 31369181
[TBL] [Abstract][Full Text] [Related]
17. Vascular comorbidities in the onset and progression of multiple sclerosis.
Tettey P; Simpson S; Taylor BV; van der Mei IA
J Neurol Sci; 2014 Dec; 347(1-2):23-33. PubMed ID: 25454639
[TBL] [Abstract][Full Text] [Related]
18. Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures.
Flauzino T; Simão ANC; de Carvalho Jennings Pereira WL; Alfieri DF; Oliveira SR; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
Metab Brain Dis; 2019 Oct; 34(5):1401-1413. PubMed ID: 31302813
[TBL] [Abstract][Full Text] [Related]
19. Clinical and diagnostic features of patients with familial multiple sclerosis.
Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A
Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766
[TBL] [Abstract][Full Text] [Related]
20. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis.
Giubilei F; Antonini G; Di Legge S; Sormani MP; Pantano P; Antonini R; Sepe-Monti M; Caramia F; Pozzilli C
Acta Neurol Scand; 2002 Aug; 106(2):109-12. PubMed ID: 12100371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
